ENTITY

Cognition Therapeutics Inc (CGTX US)

2
Analysis
Health CareUnited States
Cognition Therapeutics, Inc. operates as a biopharmaceutical company. The Company discovers and develops small molecule therapeutics targeting toxic proteins that cause cognitive decline associated with alzheimer's disease and other degenerative diseases of the human brain. Cognition Therapeutics serves customers worldwide.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x